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ABSTRACT 
Objective: To assess relative comparison of stability and degradation of Methylcobalamin tablets of different brands at various storage 
circumstances. 
Methods: The comparative in vitro study of Methycobal (innovator brand) with its other 5 different brands Cobalamin, Neuromet, Incobal, Qbal and 
Mecobal was organized for evaluation of physicochemical features of hardness, thickness, friability, weight variation, disintegration time and 
accelerated stability at 3 temperatures, 25 °C, 30 °C±65 % and 40 °C±75 % respectively for 3 mo. Later all brands were passed through HPLC for 
checking the extent of degradation of drug products.  
Results: All tablet brands were within the weight variation specified limits except Mecobal with a relative standard deviation of 6.83%. The weight 
variation values of Methycobal, Cobalamin, Neuromet, Incobal, Qbal and Mecobal were 0.29%, 0.11%, 0.09%, 0.13%, 0.09% and 0.14% after friability 
test respectively as per standard limits. The average thickness of Cobalamin, Incobal and Mecobal were not within specified limits. The average hardness 
of all trades was within limits except Cobalamin and Mecobal exceeding 6kp. The disintegration time of all companies was as per specifications.  
Conclusion: Qbal was found economical and cost-effective. However, study facts unveiled no noteworthy variety in the Q. C assessments of 
Methylcobalamin brands.  
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INTRODUCTION 
Methylcobalamin, Mecobalamin, MeCbl, and MeB12 all are declared 
terms used to identify vitamin B12 [1]. MeCbl is a therapeutically active 
segment of vitamin B12
There are various preparations applied to lessen the risk of scarcity 
of vitamin B12 like mucoadhesive buccal tablets, microencapsulated 
formulations, lozenges, liposomes, buccal films, nose sprays, intra-
nasal drops, transdermal solubilized emulsions, mouth spray, gelatin 
parenteral dose shape, inhaler/pen, buccal mucoadhesion 
hydrogelic films and toothpastes etc [9, 10].  
, also applied in the management of Alzheimer’s 
sickness, rheumatoid arthritis [2]. Vitamin B12 is necessary for cellular 
DNA production and therefore playing role in variety of functions of 
tissues in the body, development of myelin sheath, systemic circulation 
and gastro epithelial linings [3, 4]. Vitamin B12 is critical for actions of 
neurons, erythrocytes (RBCs) manufacturing, and is a cofactor for three 
foremost reactions; the transfer of methylmalonic acid to succinyl 
coenzyme A; the changing of homocysteine to methionine and the 
change of 5-methyltetrahydrofolate to tetra hydro folate [5, 6]. Maternal 
vitamin B12 shortage while pregnancy or during lactation can progress 
to neural tube faults, malfunction to flourish, hypotonic state, 
abnormalities in movement, and anemic situation. Females at higher 
hazard or with recognized deficit need to be supplemented with vitamin 
B12 throughout pregnancy or during breastfeeding or giving 
nourishment [7, 8].  
MATERIALS AND METHODS 
Study design  
Comparative in vitro quality control parameters amongst the 
commercially available tablet brands of Methylcobalamin innovator 
brand compared with it’s five other different brands produced in 
Pakistan.  
Chemicals 
Methylcobalamin tablets of innovator brand Innov-B and other five 
Brands Cobalamin, Neuromet, Incobal, Qbal and Mecobal were 
chosen for the study project. 200 Tablets of each brand were 
purchased from local medicine market Quetta, Pakistan. 
Methylcobalamin was gifted by Martin Dow marker. All brands of 
Methylcobalamin contain 500 mcg. 
 
 
Fig. 1: Structure of methylcobalamin [11] 
  
Reagents for HPLC sampling 
Acetonitrile for Chromatographic process (Lichrosolv), Buffer 
solution pH 3.0+/-0.02 (20 °C), (Citrated Hcl), Mecobalamin 
reference sample, LiChrospher 100 RP-8 end-capped (10 
micrometers), Disposable filter 0.45 um. 
Instruments 
Digital Electronic Balance, Vernier caliper, Disintegrator (Pharma 
tester), Hardness tester (Pharma tester), Roche Friabilator (Pharma 
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tester), Stability chamber (Binder II-KBF720), HPLC apparatus 
(Shimadzu, LiChroCART 250-4 HPLC Cartridge) of analytical grade.  
Methodology 
The relative examination of Methylcobal with other five diverse 
companies including Cobalamin, Neuromet, Incobal, Qbal and 
Mecobal was systematized for valuation of physical and chemical 
attributes such as hardness, Thickness and Diameter, Friability, 
weight variation and accelerated steadiness at 3 temperatures, lab 
temperature, 30 °C and 40 °C by keeping relative humidity±65% 
and±75% correspondingly for 3 mo prior to stability testing as well 
as subsequently. Then innovator brand along with 5 other trades 
were passed through HPLC test for knowing the degradation of 
tablets of brands.  
Physical evaluation of methylcobalamin tablet brands 
Weight variation test  
200 tablets of each brand were weighed in isolation with the above-
mentioned Digital analytical weighing balance and average weight and 
the percentage of variance was unveiled for every brand [12]. The 
equation for calculation of percentage weight variation is given below;  
Percentage weight variation= (average weight-individual 
weight)/individual weight x 100 %. 
Thickness test 
20 tablets of each brand were employed for thickness determination 
by Vernier caliper in mm. 
Hardness test  
Tablet hardness is typically expressed as the load necessary to crush 
a tablet positioned on its perimeter and hardness is occasionally 
called tablet crushing force. The appropriateness of the tablet 
believed to mechanical stability at some point in wrapping and 
consignment would typically be forecasted on the criteria of 
hardness. The crushing potency was determined with a tablet 
hardness tester (Monsanto). Ten tablets were arbitrarily elected 
from each brand for this test [13].  
Friability test  
The trial was initiated by weighing 10 tablets overall that is 
measured as the initial weight, Wi. All the tablets being kept in the 
drum of friability tester and apparatus was revolved at 100 rpm for 
4 min (25 rpm for 1 min). Then tablets were deducted, and re-
weighed (just the intact ones). This is estimated as the ultimate 
weightage, Wf. Then the % age loss of weight of tablets was 
computed by utilizing the equation given under [13].  
Percentage friability= {(wi-wf)/wi)} x100 
Disintegration test  
Tablet disintegration was determined in the tablet disintegration 
Apparatus. 6 tablets from each brand were subjected to distilled 
water at 37 °C. The disintegration time was taken to be the time no 
particle remained on the basket of the system [14]. 
Stability studies 
All selected tablets of Methylcobalamin brands were targeted to 
constancy studies at 3 temperatures (lab temperature, 30 °C+65% 
and 40 °C+75%) for three months in stability chamber as per 




Because of the tremendous light sensitiveness of Methylcobalamin, the 
model solution and reference solution ought to be synthesized in a 
dark room. Cover the glass equipment used tightly in aluminium foil; 
darken the sample compartment of the autosampler with black paper. 
O-buffer solution pH 3, 180 ml+800 
ml+20 ml). 
Sample solution 
Weigh 10 coated tablets in 50 ml volumetric flask (equal to almost. 10 
mg of Mecobalamin) with 50 ml of H2O and shake mechanically for 60 
min, build up the volume to the spot with H2O and blend. Pass fraction of 
mixture via a disposable filter with the help of a disposable syringe. 
Standard solution 
Melt 50 mg of Mecobalamin, correctly weigh, in water for making 100 
ml. Dilute 10 ml of solution (alike to 5milli g of Mecobalamin) in 50 milli 
liters V. flask, setup the volume up to the sign with distilled water. 
Chromatographic conditions 
The Apparatus of Liquid chromatograph with mechanical injection 
system, Detector (Ultraviolet Spectrophotometer) with Wave Length 
of 351 nm having Sample Volume of 50 ul passed through a Column 
(LichroCART 250-4, LiChrospher 100 RP-8) end-capped (10 um) at a 
flow rate of 1.5 ml/minute at a temperature of 40 °C along with 
running time of 20 min and retention time around about 4 min. 
Method and assessment 
Inject the sample solution and standard solution each twofold. Find 
out the separate peak areas by integration. 
RESULTS AND DISCUSSION 
Label information of tablet brands 
The Label known information about all brands are listed in table 1.
 
Table 1: Labeling information regarding samples 
B # code B # No Pr. (10) Tabs. Mfg Date Exp Date Manufacturer 
Methycobal 129890 168 Mar-2019 Feb-2022 Hilton Pharma  
Cobalamin 9006 96.51 Apr-2019 Apr-2024 Macter International 
Neuromet Q596 133.90 Feb-2020 Feb-2023 Martin Dow Marker 
Incobal 444 78.08 Feb-2019 Feb-2022 Indus Pharma 
Qbal 19692 64.09 May19 Apr.22 Bosch Pharmaceuticals 
Mecobal 003 82.69 Feb-19 Feb-22 Nabiqasim Industries 
*Abbreviations: B # No (Batch Number), Pr. (Price), Mfg (Manufacturing Date), Exp (Expiry Date), of the total batches (n=3). 
 
Table 2: Physical manifestations of various brands 
 B-Code Color Coating 
Methycobal White Sugar Coated 
Cobalamin White Sugar Coated 
Neuromet White Sugar Coated 
Incobal White Sugar Coated 
Qbal White Sugar Coated 
Mecobal White Sugar Coated 
*Abbreviation: B-code (Batch code), of the total n=3 all batches show same color and coating. 
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Table 3: Weight uniformity of various brands 
B-codes Average weight (g) Variation (RSD) NMT (6%) 
Methycobal 0.154±0.01 3.09±0.01 
Cobalamin 0.208±0.02 4.72±0.02 
Neuromet 0.157±0.01 3.98±0.02 
Incobal  0.196±0.11 5.791±0.01 
Qbal  0.101±0.01 2.981±0.01 
Mecobal  0.018±0.11 6.83±0.21 
The values are expressed as mean±RSD = Relative Standard Deviation,n=3. NMT= Not more than 6% # Acceptance Criteria<6%. 
 
Weight uniformity of tablet samples 
All the selected tablet brands were within the weight variation 
specified limits except Mecobal with a relative standard deviation 
over 6.83% as affirmed in table 3. 
Thickness of various tablet brands 
The average thickness of Cobalamin, Incobal, and Mecobal were not 
within limits of standard specifications as revealed in table 4. 
 
Table 4: The average thickness of different batch brands 







All results values are mean of,(n=3)±SD, # Acceptance criteria<3.10 
 
Hardness of tablet brands 
The average hardness of all brands was within the limits except 
Cobalamin (10.49 kp) and Mecobal (10.462 kp) above 6kp as 
described below in table 5. 
Weight variation before and after friability tests 
The weight variation values 0.009(0.29%), 0.005(0.11%), 
0.03(0.09%), 0.003(0.13%), 0.002(0.09%) and 0.004(0.14%) of 
Innovator brand, Cobalamin, Neuromet, Incobal, Qbal and Mecobal 
after friability test respectively were within the standard limits of 
Specifications as given table 6. 
 
Table 5: The average hardness of various brands 













*Abbreviation: kp (kilopond), All results values are mean of, (n=3), 
±SD# Acceptance criteria=<8 
 
Disintegration time of tablet brands 
The disintegration time of all brands was in the range 2-20 min as 
per the standard specifications as stated under in table 7. 
 
Table 6: Weight values and variation before and after friability tests 



















The values are expressed as weight before friability-weight after friability±= Variance from the mean, of the total n=3 
 
Table 7: Average disintegration times of different sample brands 













All the values of total (n=3) are mentioned as average disintegration time, # Acceptance Criteria= 60 min. 
 
Stability studies of tablet brands 
Stability of a biopharmaceutical product can be described as the 
capacitance of a specific preparation in a definite 
container/closure system to persist within its physical, chemical, 
microbiological, hazardous, defensive and informational 
specifications [16]. 
The objective of stability is to offer substantiation on how 
the superiority of a formulation differs with time under the effect of 
a diversity of environmental aspects  
Like temperature, moisture, and light. Dilapidation is probably to 
arise under steamy environment of higher ambient temperature and 
humidity [17]. Therapeutic product stability is a multifarious 
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collective procedure which needs substantial time, expenditure, 
utilization, and methodical skills to synthesize therapeutically 
efficient formulations, efficiency, excellence and safe nature [18]. 
The results of accelerated stability at 3 temperatures, lab 
temperature, 30 °C±65%and 40 °C±75% respectively for a duration 
of 3 mo were within the specified limits as revealed in table 8. 
  
Table 8: Stability studies of chosen brands 

















































 Total (n=3) showed stability results at temp 25 °C,
 
30 °C±65% RH (Relative Humidity)and 40 °C±75% RH (Relative Humidity). 
HPLC sampling results and calculations 
The photosensitive material, mecobalamin, emerges at retention time of 
approximately 3.68 min. Usual changing in the chromatography scheme 
can essentially cause changeable investigational surroundings. The 
endeavor of this measurement is to uphold a constant extrication 
performance. The chromatogram retention time is given in fig. 2. 
The results of HPLC of tablet brands are mentioned in table 9 and 
calculations are given underneath the table 9. 
 
 
Fig. 2: HPLC results chromatogram of mecobalamin retention time 3.64 
 
Table 9: HPLC facts about different brands 
Product-B B. No Conditions Mcg/Tablet Result 
Methycobal 129890 30 °C±65%40 °C±75% 490.78490.12 98.16%98.02% 
Cobalamin 9006 30 °C±65%40 °C±75% 469.29466.96 93.86%93.39% 
Neuromet Q596 30 °C±65%40 °C±75% 508.58501.67 101.72%100.33% 
Incobal 444 30 °C±65%40 °C±75% 559.72548.57 111.94%109.71% 
Qbal 19692 30 °C±65%40 °C±75% 483.34477.23 97.88%92.32% 
Mecobal 003 30 °C±65%40 °C±75% 474.26471.62 94.85%94.32% 
*Abbreviations: B. No (Batch number), Mcg (Microgram) at temp 25 °C,30 °C±65% RH (Relative Humidity)and 40 °C±75% RH (Relative Humidity) =. 
Results 
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x wtstd x 10 x 50 x P x Av. wt x 1000 = mcg Mecobalamin/tablet 
s
Where,  
 x 100 x 50 x wtsp x 100 
As
A
 =Peak area of the sample solution  
st =
Wtstd = Weight of standard taken, in mg Wtsp= Weight of the 
sample taken, in mg 
 Peak area of the standard solution P= Purity of the standard, in 
% 
Av. Wt =Average weight of the tablets 
CONCLUSION 
It was noticed that a larger discrepancy in worth in the identical 
generic brands of Methylcobalamin. Qbal with cost 64.09 Pakistani 
rupees/ten tablets was observed commercially efficient. 
Nevertheless, as per the consequences of present readings disclosed 
no significant diversity in the qualitative analysis of 
Methylcobalamin brands. The superiority in stipulations of weight, 
thickness, disintegration, Friability and chemical evaluation (HPLC) 
were appraised, compared and found equivalent to one and other. 
Stability testing indicated every brand is comparable to other. 
Consequently, this is demonstrating that less rated medicines also 
offer excellent biopharmaceutical beneficial outcomes. Hence, it was 
summed up that the worth effectual drug ought be employed and 
may be recommended. 
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